Kevin G Lynch
Overview
Explore the profile of Kevin G Lynch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
3428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sheline Y, Thase M, Hembree E, Balderston N, Nitchie F, Batzdorf A, et al.
Mol Psychiatry
. 2025 Mar;
PMID: 40069356
The goals of the current study were to determine the efficacy in major depressive disorder (MDD) of a shortened, computer-augmented cognitive behavioral therapy (CCBT) protocol and to determine brain plasticity...
2.
Kranzler H, Stone A, Schichman S, Griffin L, Roggenkamp H, Thase M, et al.
Psychopharmacol Bull
. 2025 Jan;
55(1):8-25.
PMID: 39744412
Background: Immunologic measures have been studied as predictors of who will respond to standard antidepressants. Two previous, small studies of pretreatment leukocyte mRNA expression levels of the cytokines macrophage migration...
3.
Nitchie F, Casalvera A, Teferi M, Patel M, Lynch K, Makhoul W, et al.
Mental Health Sci
. 2024 Sep;
2(3).
PMID: 39310119
Past research has shown that the bilateral dorsolateral prefrontal cortices (dlPFC) are implicated in both emotional processing as well as cognitive processing, in addition to working memory. Exactly how these...
4.
Shi Z, Li X, Todaro D, Cao W, Lynch K, Detre J, et al.
Transl Psychiatry
. 2024 Sep;
14(1):360.
PMID: 39237534
Opioid use disorder (OUD) has been linked to macroscopic structural alterations in the brain. The monthly injectable, extended-release formulation of μ-opioid antagonist naltrexone (XR-NTX) is highly effective in reducing opioid...
5.
Sheline Y, Makhoul W, Batzdorf A, Nitchie F, Lynch K, Cash R, et al.
JAMA Psychiatry
. 2024 Jul;
81(9):936-941.
PMID: 38985492
Importance: Bipolar disorder (BD) is chronic and disabling, with depression accounting for the majority of time with illness. Recent research demonstrated a transformative advance in the clinical efficacy of transcranial...
6.
Casalvera A, Goodwin M, Lynch K, Teferi M, Patel M, Grillon C, et al.
Soc Cogn Affect Neurosci
. 2024 May;
19(1).
PMID: 38809714
Elevated arousal in anxiety is thought to affect attention control. To test this, we designed a visual short-term memory (VSTM) task to examine distractor suppression during periods of threat and...
7.
Teferi M, Gura H, Patel M, Casalvera A, Lynch K, Makhoul W, et al.
Neuropsychopharmacology
. 2024 May;
49(10):1619-1629.
PMID: 38740902
Repetitive transcranial magnetic stimulation (rTMS) treatment protocols targeting the right dlPFC have been effective in reducing anxiety symptoms comorbid with depression. However, the mechanism behind these effects is unclear. Further,...
8.
Shi Z, Wang A, Liu J, Audrain-McGovern J, Lynch K, Loughead J, et al.
medRxiv
. 2024 Jan;
PMID: 38260670
Introduction: Graphic warning labels (GWLs) are widely employed to communicate smoking-related health risks; however, their implementation in the US has been held back by concerns about their efficacy. Most GWLs...
9.
Blanchard B, Lynch K, Malte C, Hawkins E, DePhilippis D, Oslin D, et al.
Drug Alcohol Depend Rep
. 2023 Aug;
8:100183.
PMID: 37637231
Introduction: The Brief Addiction Monitor-Revised (BAM-R) is a widely used, 17-item assessment of substance use, risk, and protective factors associated with recovery from substance use disorders. Despite wide adoption in...
10.
Li X, Langleben D, Lynch K, Wang G, Elman I, Wiers C, et al.
Front Psychiatry
. 2023 Aug;
14:1247961.
PMID: 37599869
Background: Excessive consumption of opioids is associated with impaired metabolic function including increased body mass index (BMI). Opioid antagonist naltrexone (NTX) is an effective treatment for opioid use disorder (OUD)...